ALLcrimesfood&drugstaxestelecomcommercehealthconservationtransportationagricultureveteransbrowse all titles »
0

42 U.S.C. § 287a–1Office of Rare Diseases

submitted 82 years ago by Pub. L. 107-280 to r/title-42-THE-PUBLIC-HEALTH-AND-WELFARE · 323 words · no verdicts yet

in plain englishAI-generated · not legal advice

This law creates an Office of Rare Diseases inside the Center, led by a Director. The Director plans rare-disease research, coordinates NIH institutes, and advises NIH's Director. A rare disease is one affecting fewer than 200,000 people in the United States.

(a) Establishment. The Center creates an office called the Office of Rare Diseases (the Office). The Center's Director appoints someone to run it as the Office's Director. (b) Duties. (1) The Office's Director must: (A) recommend a plan for research on rare diseases across NIH's research institutes and centers, covering a wide range of research and education activities, including scientific workshops and seminars to spot research opportunities; (B) help NIH's institutes and centers, and the outside groups they fund, coordinate and cooperate on rare-disease work; (C) team up with the directors of other relevant NIH institutes and centers to make cooperative agreements and grants for regional rare-disease centers of excellence, under section 287a–2; (D) push for NIH to give enough resources to rare-disease research; and (E) promote and encourage a central clearinghouse for rare and genetic disease information, written so the public, medical professionals, patients, and families can understand it. (2) On rare diseases, the Office's Director is the main advisor to NIH's Director and also advises other relevant agencies. The Director also serves as the liaison to national and international patient, health, and scientific groups focused on rare diseases. (c) Definition. In this section, "rare disease" means any disease or condition affecting fewer than 200,000 people in the United States.
the actual law source: uscode.house.gov ↗public domain
(a) Establishment

There is established within the Center an office to be known as the Office of Rare Diseases (in this section referred to as the “Office”), which shall be headed by a Director (in this section referred to as the “Director”), appointed by the Director of the Center.

(b) Duties
(1) In general

The Director of the Office shall carry out the following:

(A)

The Director shall recommend an agenda for conducting and supporting research on rare diseases through the national research institutes and centers. The agenda shall provide for a broad range of research and education activities, including scientific workshops and symposia to identify research opportunities for rare diseases.

(B)

The Director shall, with respect to rare diseases, promote coordination and cooperation among the national research institutes and centers and entities whose research is supported by such institutes.

(C)

The Director, in collaboration with the directors of the other relevant institutes and centers of the National Institutes of Health, may enter into cooperative agreements with and make grants for regional centers of excellence on rare diseases in accordance with section 287a–2 of this title.

(D)

The Director shall promote the sufficient allocation of the resources of the National Institutes of Health for conducting and supporting research on rare diseases.

(E)

The Director shall promote and encourage the establishment of a centralized clearinghouse for rare and genetic disease information that will provide understandable information about these diseases to the public, medical professionals, patients and families.

(2) Principal advisor regarding orphan diseases

With respect to rare diseases, the Director shall serve as the principal advisor to the Director of NIH and shall provide advice to other relevant agencies. The Director shall provide liaison with national and international patient, health and scientific organizations concerned with rare diseases.

(c) Definition

For purposes of this section, the term “rare disease” means any disease or condition that affects less than 200,000 persons in the United States.

Source credit: (July 1, 1944, ch. 373, title IV, § 481, formerly § 404F, as added Pub. L. 107–280, § 3, Nov. 6, 2002, 116 Stat. 1989; amended Pub. L. 109–482, title I, §§ 103(b)(5), 104(b)(1)(B), Jan. 15, 2007, 120 Stat. 3687, 3693; renumbered § 481 and amended Pub. L. 112–74, div. F, title II, § 221(c)(2)(A), Dec. 23, 2011, 125 Stat. 1089.)

history & why it existsrecord from the source credit
  • 1944Enacted · Pub. L. 107-280 · 116 Stat. 1989
  • 2007Amended · Pub. L. 109-482 · 120 Stat. 3687, 3693
  • 2011Amended · Pub. L. 112-74 · 125 Stat. 1089

A history note hasn’t been published yet. The record shows enactment by Pub. L. 107-280 on 1944-07-01.

all 0 arguments · sorted by: best

0/280

no arguments yet — make the first case